Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01922323 · ClinicalTrials.gov registry record
Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors
A clinical trial of Liver Insufficiency, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT01922323: Completed study of Liver Insufficiency, sponsored by Baylor Research Institute.
NCT01922323 is a study of Liver Insufficiency that has completed, run by Baylor Research Institute. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01922323, a study of Liver Insufficiency, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The PI will study metabolism during liver regeneration in living liver donors
Conditions Studied
Study Locations (1)
Texas
- Baylor University Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-09-26 |
What the finished NCT01922323 record still lists
NCT01922323 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Liver Insufficiency appearing as the primary indexed condition, and to 0 interventions.
NCT01922323 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01922323 about?
NCT01922323 is a clinical study titled "Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors". The PI will study metabolism during liver regeneration in living liver donors
What is the current status of trial NCT01922323?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2013-08. Estimated completion is 2016-09-26.
What conditions does trial NCT01922323 study?
This clinical trial studies the following conditions: Liver Insufficiency.
Who is sponsoring clinical trial NCT01922323?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01922323 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia